Panel Discussion | DCB for Coronary Applications

Monday, March 10, 2025

9:04 AM – 9:20 AM ET

Panel Moderator(s)

Bernardo Cortese, MD, FESC, FSCAI

Director of Coronary Program
University Hospitals
Cleveland, Ohio, United States

Disclosure information not submitted.
Bruno Scheller, MD

Professor of Clinical and Experimental Interventional Cardiology
University of Saarland
Homburg, Saarland, Germany

Disclosure(s): B.Braun: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Medtronic: Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)
Renu Virmani, MD

President
CVPath Institute, Inc.
Gaithersburg, Maryland, United States

Disclosure information not submitted.

Panel Discussant(s)

George Adams, MD MHS MBA FACC FSCAI

Chief Medical Officer, Cordis
Cordis, North Carolina, United States

Disclosure information not submitted.
Fernando Alfonso, MD

Head, Department of Cardiology
Hospital Univeritario La Princesa, Madrid

Disclosure information not submitted.
Sandeep Basavarajaiah, MBBS, MD, MRCP, FESC

Consultant Cardiologist
National Health Service

Disclosure(s): Concept Medical, CSL Behring, Cytosorbents, Daiichi Sankyo, Element Science, Faraday, Filterlex Medical, Humacyte, Idorsia Pharmaceuticals, Janssen, Mediasphere, Medtelligence: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)
Ricardo A. Costa, MD, PhD

Interventional Cardiologist - Percutaneous Intervention Research Medical Section Chief
Institute Dante Pazzanese of Cardiology
Sao Paulo, Sao Paulo, Brazil

Disclosure information not submitted.
Debabrata Dash, MD, DM, FICC, FSCAI, FAPSC, FCCP, FACC, FESC

Consultant Interventional Cardiologist
Aster Hospital, Al Mankhool Dubai, UAE
Dubai, Dubai, United Arab Emirates

Disclosure(s): No financial relationships to disclose
Aloke V. Finn, MD

President CVPath/Prof. Of Medicine University of Maryland
CVPath
Gaithersburg, Maryland, United States

Disclosure information not submitted.
Michael Haude, MD, PhD

Director of the Heart & Vascular Center
Rheinland Klinikum Neuss GmbH
Neuss, Germany

Disclosure information not submitted.
Patrick W. Serruys, MD, PhD

Professor of Medical Intervention & Innovation
University of Galway, Ireland

Disclosure information not submitted.
UT

Ulf Teichgräber, MD

Chair
University Hospital Jena, Friedrich-Schiller-University
Jena, Germany

Disclosure information not submitted.

Disclosure(s):

Bruno Scheller, MD: B.Braun: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Medtronic: Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)

Sandeep Basavarajaiah, MBBS, MD, MRCP, FESC: Concept Medical, CSL Behring, Cytosorbents, Daiichi Sankyo, Element Science, Faraday, Filterlex Medical, Humacyte, Idorsia Pharmaceuticals, Janssen, Mediasphere, Medtelligence: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)

Debabrata Dash, MD, DM, FICC, FSCAI, FAPSC, FCCP, FACC, FESC: No financial relationships to disclose

Eleni Whatley, PhD: No financial relationships to disclose